Foundation Fighting Blindness

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Foundation Fighting Blindness sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed early-phase tilt upper quartile by trial count

Foundation Fighting Blindness: 3 sponsored US clinical trials, 1 recruiting.

Foundation Fighting Blindness sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cone Dystrophy, with 1 trials.

Upper-quartile sponsor footprint

Foundation Fighting Blindness sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Inherited Retinal Degenerative Disease Registry

NCT02435940
COMPLETED

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

NCT01977846
COMPLETED Phase 2

Trial of Oral Valproic Acid for Retinitis Pigmentosa

NCT01233609

Phase Distribution

PhaseTrial count
Phase 2 1

Therapeutic Areas

Cone Dystrophy 1
Choroidal Dystrophy 1
Best Disease 1
Batten Disease 1
Bassen-Kornzweig Syndrome 1
Achromatopsia 1
Bardet-Biedl Syndrome 1
Choroideremia 1
Retinitis Pigmentosa 1
Retinal Disease 1

What is open in the Foundation Fighting Blindness pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Cone Dystrophy (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Foundation Fighting Blindness: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Foundation Fighting Blindness sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Foundation Fighting Blindness10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Foundation Fighting Blindness sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Foundation Fighting Blindness sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Foundation Fighting Blindness page

3 registered trials is a research-attention snapshot, not an endorsement of Foundation Fighting Blindness or any single study.

  • 1 of Foundation Fighting Blindness's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cone Dystrophy is the condition Foundation Fighting Blindness studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cone Dystrophy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Foundation Fighting Blindness pipeline card: 3 registered trials from official public datasets.Report a data error.